Institution
Université catholique de Louvain
Education•Louvain-la-Neuve, Belgium•
About: Université catholique de Louvain is a education organization based out in Louvain-la-Neuve, Belgium. It is known for research contribution in the topics: Population & Catalysis. The organization has 25319 authors who have published 57360 publications receiving 2172080 citations. The organization is also known as: University of Louvain & UCLouvain.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The role of soil erosion in terrestrial carbon sequestration and release remains one of the most important uncertainties in our attempts to determine the potential of soils to mediate climate change as discussed by the authors.
343 citations
•
01 Nov 2004TL;DR: In this article, the authors introduce 2-D wavelets via 1-D continuous wavelet transforms, which offer a number of advantages over discrete wavelet transform for analysis of real-time signals in such areas as medical imaging, fluid dynamics, shape recognition, image enhancement and target tracking.
Abstract: Two-dimensional wavelets offer a number of advantages over discrete wavelet transforms when processing rapidly varying functions and signals. In particular, they offer benefits for real-time applications such as medical imaging, fluid dynamics, shape recognition, image enhancement and target tracking. This book introduces 2-D wavelets via 1-D continuous wavelet transforms. The authors then describe the underlying mathematics before progressing to more advanced topics such as matrix geometry of wavelet analysis and three-dimensional wavelets. Practical applications and illustrative examples are employed extensively throughout, ensuring the book's value to engineers, physicists and mathematicians. Two-dimensional wavelets offer a number of advantages over discrete wavelet transforms, in particular, for analysis of real-time signals in such areas as medical imaging, fluid dynamics, shape recognition, image enhancement and target tracking.
343 citations
••
TL;DR: The aim of this review is to summarize and discuss the data showing an influence of inflammatory mediators and related free radicals on the expression and activity of glial glutamate transporters.
Abstract: Oxidative stress, neuroinflammation, and excitotoxicity are frequently considered distinct but common hallmarks of several neurological disorders, including Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and Alzheimer's disease. Although neuron degeneration and death are the ultimate consequences of these pathological processes, it is now widely accepted that alterations in the function of surrounding glial cells are key features in the progression of these diseases. In response to alteration in their local environment, microglia, commonly considered the resident immune cells of the nervous parenchyma, become activated and release a variety of soluble factors. Among these, proinflammatory cytokines and free radicals actively participate in the degenerative insults. In addition, excitotoxic neuronal damage resulting from excessive glutamate is frequently associated with impaired handling of extracellular glutamate by gliotic astrocytes. Although several research projects have focused on the biochemical mechanisms of the regulation of glial glutamate transporters, a relationship between activation of microglia and modulation of astrocytic glutamate uptake is now suggested. The aim of this review is to summarize and discuss the data showing an influence of inflammatory mediators and related free radicals on the expression and activity of glial glutamate transporters.
343 citations
••
TL;DR: The present study shows that MCD diet‐induced fibrosing steatohepatitis can be reversed by treatment with Wy‐14,643, and it is likely that activation of PPARα reverses fibrosis indirectly by reducing stimuli, such as lipid peroxides, and activation of cells responsible for promoting hepatic fibrosis.
342 citations
••
TL;DR: Four leading cancer immunologists around the world say that tumour immunogenicity varies greatly between cancers of the same type in different individuals and between different types of cancer.
Abstract: Many standard and targeted therapies, as well as radiotherapy, have been shown to induce an anti-tumour immune response, and immunotherapies rely on modulating the host immune system to induce an anti-tumour immune response. However, the immune response to such therapies is often reliant on the immunogenicity of a tumour. Tumour immunogenicity varies greatly between cancers of the same type in different individuals and between different types of cancer. So, what do we know about tumour immunogenicity and how might we therapeutically improve tumour immunogenicity? We asked four leading cancer immunologists around the world for their opinions on this important issue.
342 citations
Authors
Showing all 25540 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert Langer | 281 | 2324 | 326306 |
Pulickel M. Ajayan | 176 | 1223 | 136241 |
Klaus Müllen | 164 | 2125 | 140748 |
Giacomo Bruno | 158 | 1687 | 124368 |
Willem M. de Vos | 148 | 670 | 88146 |
David Goldstein | 141 | 1301 | 101955 |
Krzysztof Piotrzkowski | 141 | 1269 | 99607 |
Andrea Giammanco | 135 | 1362 | 98093 |
Christophe Delaere | 135 | 1320 | 96742 |
Vincent Lemaitre | 134 | 1310 | 99190 |
Michael Tytgat | 134 | 1449 | 94133 |
Jian Li | 133 | 2863 | 87131 |
Jost B. Jonas | 132 | 1158 | 166510 |
George Stephans | 132 | 1337 | 86865 |
Peter Hall | 132 | 1640 | 85019 |